We have cloned the region of tomato ringspot nepovirus (TomRSV) RNA-1 coding for the putative TomRSV 3C-related protease (amino acids 1213 to 1508) in a transcription vector and in a transient expression vector. Using cell-free transcription and translation systems and plant protoplasts, we have demonstrated that proteins produced from these clones possess a proteolytic activity in trans on the cleavage site between the TomRSV movement and coat proteins. By amino acid homology of the TomRSV 3C-related protease with other nepoand comovirus proteases, His 1283, Glu 1331 (or Asp TM) and Cys 1433 have been predicted to constitute the catalytic triad. Site-directed mutagenesis of His 1283 to Asp abolished the TomRSV protease activity, in vitro and in vivo. The cleavage site between the TomRSV movement and coat proteins has been determined to be Q/G, by direct protein sequencing. Previously, His 145~ located in the substrate binding pocket of the TomRSV 3C-related protease has been suggested to be involved in the cleavage site specificity. We show that an inactive TomRSV 3C-related protease is obtained after substitution of His ~4~1 with Leu. These results are discussed in light of the possible relation of the TomRSV 3C-related protease to 3C-related proteases ofnepo-, comoand potyviruses.
Introduction
Tomato ringspot virus (TomRSV) is a member of the nepovirus group. Its genome is composed of two plus sense RNA molecules of 8214 (RNA-1) and 7273 (RNA-2) nucleotides (nt) in length (Rott et al., 1991 (Rott et al., , 1995 . Each RNA component is linked to a VPg protein at the 5' end and is polyadenylated at the 3' end. TomRSV RNA-1 and RNA-2 potentially encode polyproteins of molecular mass 244 kDa (P1) and 207 kDa (P2), respectively. The deduced TomRSV genomic organization is similar to that of the other nepoviruses, with the VPg, protease and polymerase located at the C-terminal region of P1 and the movement and coat proteins located at the C-terminal region of P2 (Rottet aL, 199t, 1995 ; for a review see Sanfaqon, 1994) . Mature TomRSV proteins are probably released from P1 and P2 by proteolytic processing as shown for two other nepoviruses: tomato black ring virus (TBRV) and grapevine fanleaf virus (GFLV) (Demangeat et al., 1990; Margis et al., 1991) . TomRSV, along with peach rosette mosaic, cherry leaf roll and myrobalan latent ringspot viruses have been classified as subgroup II nepoviruses owing to the length of RNA-2 (> 5-4 kb) (Francki et al., 1985) . TomRSV is the only sequenced member of nepovirus subgroup II. In * Author for correspondence. Fax + 1 604 666 4994. e-mail SANFACON@PARGVA.AGR.CA contrast, GFLV, TBRV, arabis mosaic virus and grapevine chrome mosaic virus (GCMV) belong to subgroup I nepoviruses because their RNA-2 component is smaller than 5.4 kb.
Picornaviruses and picorna-like viruses, including the comovirus, potyvirus and nepovirus groups (Goldbach et al., 1990) encode 3C proteases and 3C-related proteases, respectively. These proteases are homologous to the chymotrypsin-like serine proteases because their catalytic triad is constituted by His, Glu (or Asp) and Cys (Bazan & Fletterick, 1988; Gorbalenya et al., 1989) . For example, His 4°, Glu 71 and Cys 147 are the catalytic triad of the well characterized poliovirus 3C protease (numbering according to the poliovirus 3C protease) (H/immerle et al., 1991) . In addition, a highly conserved histidine (His TM, numbered according to the poliovirus 3C protease), found in all the substrate binding pockets of the 3C proteases and of the poty-and comovirus 3C-related proteases is essential for the recognition of the (Q,E)/(G,E) cleavage site consensus of picorna-, potyand comovirus polyproteins (Bazan & Fletterick, 1988 Gorbalenya et al., 1989; Allaire et al., 1994; Matthews et al., 1994) . Members of nepovirus subgroup I are an exception to this: they have a Leu in the substrate binding pocket of their 3C-related proteases, instead of the conserved His found in the substrate binding pocket of the picorna-, poty-and comovirus 3C-related proteases (Demangeat et al., 1990; Ritzenthaler et al., 1991) . This could explain why all the cleavage sites identified on polyproteins of subgroup I nepoviruses differ from the (Q,E)/(G,E) cleavage site consensus of picorna-, poty-and comovirus polyproteins (Brault et 1994) . Surprisingly, the TomRSV 3C-related protease, like the picorna-, como-and potyvirus proteases, contains the conserved His in the substrate binding pocket. This suggests that TomRSV polyprotein cleavage sites may be similar to picorna-, poty-and comovirus polyprotein cleavage sites (Rott et al., 1995) .
In this paper, we have prepared a cDNA clone corresponding to the region of the TomRSV genome encoding the 3C-related protease. Using an in vitro and in vivo system, we have shown the proteolytic activity of the protein produced from this clone. We have also characterized the cleavage site specificity of the TomRSV 3C-related protease.
Methods

Plasmid constructions
Clones pMR10 and pMR14, containing the complete sequence of TomRSV RNA-1 and TomRSV RNA-2, respectively, were described previously (Rottet al., 1991 (Rottet al., , 1995 . "
Protease clones. Plasmid pT7-PRO was constructed by amplifying a 887 nt fragment from plasmid pMR10 (nt 3714 to 4601 of TomRSV RNA-1 sequence) with Taq polymerase (Pharmacia). Oligonucleotide 17 (5' GCTCTAGACCATGGCTTCGACGATTCCCTCCGG 3') and oligonucleotide 18 (5' CGGAATTCCCACTTTAGAAACCCC 3') were used to generate the 5' and 3' ends of the fragment, respectively. To allow translation of the protein, oligonucleotide 17 contains an ATG codon (underlined in the above sequence) in frame with the TomRSV RNA-1 nucleotide sequence. Oligonucleotide 17 and oligonucleotide 18 contain respectively a XbaI and an EcoRI site that were used to subclone the PCR-amplified fragment into the polytinker of plasmid pKS(+) (Stratagene).
Plasmids pT7-PRO m2s3D and pT7-PRO m451L were obtained by sitedirected mutagenesis, after substitution of His 1283 (numbered according to TomRSV P1) by Asp and His ~451 by Leu, respectively. The method of Kunkel (1985) was employed using pT7-PRO uridyl-single-strand DNA and mutagenic oligonucleotides 24 (5' CTTTGGCTTTGACT-AAAGATCAGGCCTTAACCATAC 3') and 25 (5' CAAAATCATA-GGGATGCT_T_TGTGGCGGGATCC 3') respectively. The underlined nucleotides in the above oligonucleotides correspond to the nucleotides substituted in each clone.
Plasmids p35S-PRO, p35S-PRO H12830 and p35S-PRO TM were constructed by first subcloning the NcoI-EcoRI fragments of pT7-PRO, pT7-PRO H12s3° and pT7-PRO m451z into the polylinker of plasmid pMTL23 (Chambers et al., 1988) . This step was performed in order to insert a stop codon at the end of the three proteases. Then the XbaI-BgllI fragments were extracted from each intermediate plasmid and subcloned into the polylinker of plasmid pDH51, containing the cauliflower mosaic virus 35S promoter and polyadenylation signal (Pietrzak et al., 1986) .
Substrate clones. Plasmid p35S-MPCAT was constructed by amplifying an 802 nt fragment from plasmid pMR14 (nt 3294 to 4096 of TomRSV RNA-2 sequence) with Taq polymerase using oligonucleotides 1 (5'CGACCTGCAGAATGGCGGGGGATGCAAGCTCG 3') and 2 (5' CGACGGATCCTTCGCACAGGTAACTTTGCG 3'). To allow translation of the protein an ATG codon (underlined in the above sequence) was included in oligonucleotide 1 in frame with the TomRSV RNA-2 sequence. A PstI site on oligonucleotide 1 and a BamHI site on oligonucleotide 2 were used to subclone this fragment into the polylinker of plasmid pCAMVCN (Pharmacia). Because an additional PstI site is present on plasmid pCAMVCN downstream of the CAT gene, the ligation was performed on three fragments: the PstI-BamHI digest of the PCR-amplified fragment, the 1072nt BamHI-ClaI fragment of pCAMVCN and the 3093 nt PstI-ClaI fragment of pCAMVCN. The resulting plasmid contained an Nterminal fusion of the TomRSV RNA-2 in frame with the chloramphenicol acetyltransferase (CAT) gene, under the control of the 35S promoter.
Plasmid pT7-MPCAT was constructed by cloning the PstI-PstI fragment of p35S-MPCAT into the PstI site of the polylinker of plasmid pKS( + ).
Plasmid pT7-MPCP was constructed by amplifying an 1870nt fragment from plasmid pMR14 (nt 3294 and 5164 of the TomRSV RNA-2 sequence) with Taq polymerase using oligonucleotides 1 (described above) and 15 (5' GGAAGGCGAGCCGGCC 3'). The PstI site on oligonucleotide 1 and a PstI site present on the amplified product at position 4993 (numbered according to the TomRSV RNA-2 sequence) was used to obtain a 1699 nt fragment which was further subcloned into the PstI site of the polylinker of plasmid pKS(+).
Plasmids pT7-MPCPAQG and pT7-MPCPAEG were obtained after deletion of the sequence corresponding to the dipeptide QG at position 1320 to 1321 (numbered according to TomRSV P2) and after deletion of the sequence corresponding to the dipeptide EG at position 1326-1327, respectively. The method of Kunkel (1985) was employed using pT7-MPCP uridyl single-strand DNA and mutagenic oligonucleotides 22 (5' GGAATTCTTCTGTTGGGTCCTGGC 3') and 23 (5' GGGTCCTGGCAAACTGAAGCCGC Y), respectively.
Constructs described above were transfected in E. coli strain JM109 by electroporation (Pfau & Youderian, 1990 ) and the structure of recombinant plasmids was verified by restriction enzyme digestion and DNA sequencing (Sambrook et al., 1989) .
In vitro transcription and translation. Run-off transcripts were synthesized from linearized plasmids using bacteriophage T7 RNA polymerase (Stratagene) (Sambrook et al., 1989) , purified by phenolchloroform extractions and precipitated with 2 M-LiCk [a~S]Methionine labelled translation products were synthesized in a micrococcal nuclease-treated rabbit reticulocyte lysate system (NT-RRLS) (Promega) as described by Margis et al. (1991) . Unlabelled translation products were synthesized as described above but [zSS]methionine was omitted and replaced by cold methionine as described by the supplier. After 1 h at 30 °C, RNase A at 50 ng/lal was added for 10 min at 30 °C in order to eliminate the RNA template.
Maturation studies were performed at 30 °C by adding 5 gl of unlabelled protease translation products to 1 lal of [35S]methionine labelled substrate translation products. After 3 h of incubation, reactions were stopped by the addition of an equal volume of electrophoresis loading buffer (62-5 mM-Tris-HC1 pH 6"8, 10 % glycerol, 5% ~-mercaptoethanol, 2% SDS, 0.01% bromophenol blue). Samples were boiled for 2min and fractionated in 12% or 15% SDS-polyacrylamide gels, according to Laemmli (1970) .
Protoplast transfection. Protoplasts from Nicotiana plumbaginifolia were prepared and transfected as described by Negrutiu et al. (1987) . Samples of 6x 105 protoplasts were used for polyethylene glycol transfection using 10 gg of each plasmid. After 24 h of culture at 26 °C in the dark, protoplasts were harvested and soluble extracts of proteins were prepared as described by FOtterer et al. (1989 The N and C termini of TomRSV, TBRV and GCMV proteases and the C terminus of the GFLV 3C-related protease were arbitrarily chosen since the cleavage sites producing these proteases are unknown. The aligned sequences are numbered according to polyprotein P1 encoded by TomRSV RNA-1. His n~, Glu 'a~l and Cys 14~, which in homology to the catalytic triads of CPMV and GFLV (Dessens & Lomonossoff, 1991 ; Margis & Pinck, 1992) probably constitute the TomRSV catalytic triad, are shown in black boxes. Asp TM, which may be an alternative to Glu lzzl in the TomRSV catalytic triad (as demonstrated for TEV, Dougherty et al., 1989a) , is shown in the grey box. His la~, which is also found in the substrate binding pocket of the CPMV protease and the leucines found at the equivalent position in the substrate binding pocket of subgroup I nepovirus proteases, are shown in the white box. Hydrophobic amino acids found in all the reported proteases and potentially belonging to the substrate binding pocket are boxed with dotted lines. Amino acids of TomRSV protease that have been mutated are labelled (*).
protoplasts, CAT assays were performed, as described by Neumann et al. (1987) , by measuring the rate of conversion of [*4C]acetyl-CoA to [*4C]acetylated chloramphenicol/million protoplasts. When labelling of protoplasts was required, 25 ~tCi (0-92 MBq) [35S]methionine (1000Ci/mmot; Amersham) was added, 18 h after transfection, to samples of 3 x 105 protoplasts resuspended in 0.5 ml of culture medium, for a period of 6 h.
Immunoprecipitation. Pelleted, 35S-labelled protoplasts or in vitro labelled translation products were diluted with 1 vol. of dissociation buffer (125 mM-Tris-HCl pH 6-8, 25 % fl-mercaptoethanol, 10 % SDS), boiled for 3 min and diluted 10-fold with PBS-TDS buffer (150 mMNaC1, 1 mM-KH~PO4, 8 mM-Na~HPO4, 2 m~-KC1, 1% Triton X-100, 0.5 % sodium deoxycholate, 0.1% SDS). Ascites fluid (1 Ixl) containing a monoclonal antibody against the movement protein (MP antibody) (Wieczorek & Sanfagon, 1993) or 5 }xl of a polyclonal antibody directed against the CAT protein (CAT antibody) (Boehringer Mannheim) was added. Samples were incubated overnight at 4 °C and immunoprecipitated with 25 ttl of 10 % Protein A-or protein G-Sepharose CL-4B (Sigma) for 1 h at 4 °C with rotatory shaking. Immunoprecipitates were washed five times in PBS-TDS buffer, resuspended in 25 ~tl of dissociation buffer containing 0.01% bromophenol blue and analysed on SDS-polyacrylamide gels.
N-Terminal sequence analysis of the viral coat protein.
TomRSV was propagated in cucumber plants and virus was extracted from systemically infected leaves 12 days after inoculation. Leaves were ground in 50 mM-borate buffer pH 7 and filtered through cheesecloth. After clarification of the extract at 7000 g for 30 min, precipitation of the cellular proteins with 15 % (NH4)~SO 4 and a second clarification, the TomRSV virions were concentrated by ultracentrifugation at 96000g for 2 h. The pellet was resuspended in 50 mM-borate buffer pH 7 and purified through a 4 M-caesium chloride gradient at 14000 g, for 16 h. The band of virions was collected and dialysed against 20 mMborate buffer, pH 7. Coat protein (150 pmol) was loaded onto a 10% SDS-polyacrylamide gel, transferred onto polyvinylidene difluoride protein sequencing membrane (Bio-Rad) as described by the supplier and subjected directly to automated Edman degradation.
Computer analysis. Sequence alignments between the TomRSV 3C-related protease, the 3C-related proteases of three subgroup I F. Hans and H. Sanfa~on In plasmids pMR10 and pMR14 (corresponding to fulllength cDNA clones of TomRSV RNA-1 and RNA-2, respectively, and coding for the TomRSV polyproteins P1 and P2, respectively), the approximate location of the VPg, protease (PRO), polymerase (POL), movement protein (MP) and coat protein (CP) are shown. TomRSV polyprotein P1 putative cleavage sites are represented by single vertical lines. The MP-CP cleavage site (.9) located on polyprotein P2 is also indicated. Flags above polyproteins P1 and P2 represent the oligonucleotides used to construct plasmids pT7-PRO, pT7-MPCAT and pT7-MPCP. The PstI site used to construct clone pT7-MPCP is shown. Numbers below each ORF correspond to amino acids numbered according to P1 and P2. In pT7-PRO, amino acids belonging to the potential catalytic triad of the TomRSV 3C-related protease are indicated. His 145a, belonging to the putative substrate binding pocket, is underlined. The MPCAT fusion protein contains the TomRSV RNA-2 region (white box), coding for the C-terminal region of the TomRSV movement protein (AMP), the MP-CP cleavage site (.9) and the C-terminal region of the coat protein (CP'), in frame with the CAT protein (black box). The MPCAT start and the internal initiator codons, and the CAT start codon are indicated. Tr-MPCAT translation products and their expected molecular mass before (MPCAT) and after (AMP and CPCAT) processing are indicated by thick lines. The translation product of tr-MPCAT (and its expected molecular mass) after internal initiation at the CAT start codon is represented by a thick dotted line (CAT). nepoviruses (GFLV, TBRV and GCMV) and the cowpea mosaic virus (CPMV) 3C-related protease were performed using the PILEUP program (Devereux et al., 1984) .
Results
Genomic localization and cDNA cloning of the TomRSV 3C-related protease
Based on amino acid sequence alignments between TomRSV polyproteins and polyproteins encoded by subgroup I nepoviruses (GFLV, TBRV and GCMV), a comovirus (CPMV), a potyvirus (tobacco etch virus, TEV) and a picornavirus (poliovirus), Rott et al. (1995) located the potential TomRSV 3C-related protease on TomRSV polyprotein P1. Using the models of Bazan & Fletterick (1988) and Gorbalenya et al. (1989) , amino acid sequence alignments published by Rott et al. (1995) and our own amino acid sequence alignments ( Fig. 1 Based on the above information, the clone pT7-PRO, encoding the potential TomRSV protease, was constructed using the method of Margis et al. (1991) . A PCR product, encompassing the potential TomRSV protease region (amino acids 1213 to 1508) was obtained using plasmid pMR10 as template (Rott et al., 1995) and primers 17 and 18 (see Methods and Fig. 2a) . The unique XbaI and EcoRI restriction sites present on primers 17 and 18, respectively, were used to place the PCRamplified fragment under the control of the T7 promoter. As primer 17 also contains a NcoI site, an ATG start codon was introduced in frame with the amplified TomRSV RNA-1 sequence. This would allow the translation of a 32 kDa protein corresponding to the putative TomRSV 3C-related protease, probably flanked by the entire putative VPg and by 42 amino acids downstream from the potential Q/M cleavage site between the protease and the polymerase (Fig. 2a) . In vitro transcription of EcoRI-linearized pT7-PRO gave transcript tr-PRO. In vitro translation of tr-PRO in a micrococcal nuclease-treated rabbit reticulocyte lysate system (NT-RRLS) for 1 h, in the presence of [35S]methionine, resulted in one major labelled protein of 32 kDa (data not shown).
In trans cleavage by the TomRSV protease in vitro
Experiments were designed to determine whether the TomRSV protease was able to recognize and to process in trans cleavage sites on the TomRSV polyprotein P2. NT-RRLS was chosen rather than wheat germ extract because proteolytic processing can be inhibited in wheat germ extract (Shih et al., 1987; Margis et al., 1991) . In vitro translation of the entire P2 coding region resulted in a very complex banding pattern (data not shown), presumably due to internal initiation or premature termination event, or to degradation of the very long polyprotein P2 (207 kDa). We decided to test the proteolytic activity of the TomRSV 3C-related protease on an isolated P2 cleavage site. We chose the cleavage site between the movement and coat protein (MP~CP cleavage site), because a monoclonal antibody against the movement protein (MP antibody) was available (Wieczorek & Sanfaqon, 1993) . The chimeric pT7-MPCAT clone was constructed as follows: a PCR product, corresponding to the TomRSV RNA-2 region from amino acids 1073 to 1340 was obtained, using plasmid pMR14 as template (Rott et al., 1991) and primers 1 and 2 (see Methods and Fig. 2a) . According to the estimated molecular masses of the TomRSV movement and coat proteins (Wieczorek & Sanfagon, 1993; Allen & Dias, 1977) , the PCR-amplified fragment contains approximately 30 kDa of the coding region of the C-terminal extremity of the TomRSV movement protein (AMP) and 2 kDa of the coding region of the Nterminal extremity of the coat protein (CP'). The PCR product was further cloned in frame with the CAT reporter gene. The entire insert was placed under the control of the T7 promoter. An ATG codon, present on primer 1, was introduced in frame with the insert in order to allow the translation of the MPCAT fusion protein with a predicted molecular mass of 56 kDa. Because the MPCAT fusion protein should contain the MP-CP cleavage site, we predicted that it would be processed by the TomRSV 3C-related protease to give the AMP protein and the CPCAT protein with a predicted molecular mass of 26 kDa, containing approximately 2 kDa of the N-terminal extremity of the CP followed by 24 kDa of the CAT protein (Fig. 2 a) .
Digestion of plasmid pT7-MPCAT by XhoI followed by transcription with bacteriophage T7 RNA polymerase produced transcript tr-MPCAT. Translocation of trtr-MPCAT translation products as substrate and unlabelled translation products of tr-PRO (Lane 1), tr-PRO m28zD (PRO HI~s3D) (lane 3) and tr-PRO r~1451z (PRO m4~L) (lane 4) as a potential source of protease. Lane 2, [*SS]methionine labelled tr-MPCAT translation products.
MPCAT in NT-RRLS for 1 h, in the presence of [35S]methionine, produced three major labelled proteins of apparent molecular masses 59 kDa, 58 kDa and 24 kDa. The same pattern was obtained after 4 h of incubation, in the presence of a fivefold excess of micrococcal nuclease-treated rabbit reticulocyte lysate, proving that the NT-RRLS did not contain endogenous proteolytic activity (Fig. 2b, lane 1) . To further characterize these three labelled proteins, immunoprecipitations using various antibodies were performed. The 59 kDa protein was immunoprecipitated by the MP antibodies and also by CAT antibodies (Fig. 2c, lanes 2 and 4) , demonstrating that this protein corresponded to the MPCAT fusion protein. The difference between the calculated and apparent molecular mass of the MPCAT fusion protein could be explained by abnormal migration of the translation products in SDS-polyacrylamide gels. The less abundant 58 kDa protein also reacted with both antibodies (Fig. 2c, lanes 2 and 4) , suggesting that this protein was also an MPCAT fusion protein. This protein may be produced by an internal initiation at the methionine located 19 amino acids downstream from the initiator codon (Fig. 2a) . The 24 kDa protein was immunoprecipitated only by CAT antibodies (Fig. 2c,  lanes 2 and 4) . Thus, we conclude that the 24 kDa protein is the CAT protein synthesized by internal initiation at the initiator AUG codon of the CAT gene.
The proteolytic activity of the complete TomRSV P1, encoded by plasmid pMR10 (Rott et al., 1995) and of the potential TomRSV protease, encoded by plasmid pT7-PRO, was assayed in trans on the MP-CP cleavage site present in the MPCAT fusion protein. Plasmids pMR10 and pT7-PRO were linearized by XbaI and EcoRI, respectively, and transcriptions were carried out with T7 RNA polymerase to give transcripts tr-TomRSV RNA-1 and tr-PRO. Unlabelled translations of tr-TomRSV RNA-1 and tr-PRO and [35S]methionine labelled translations of tr-MPCAT were done separately in NT-RRLS for 1 h. Maturation experiments were performed by incubating [35S]methionine labelled tr-MPCAT translation products with either unlabelled tr-TomRSV RNA-1 translation products or unlabelled tr-PRO translation products, for 3 h. The pattern of [3~S]methionine labelled tr-MPCAT translation products obtained after maturation experiments revealed the presence of three additional proteins of 33 kDa, 32 kDa and 26 kDa (Fig.  2b, lanes 2 and 3) . The 33 kDa and 32 kDa proteins were immunoprecipitated only by MP antibodies (Fig. 2c,  lanes 3 and 5) and therefore correspond to AMP, released after processing of the MPCAT fusion protein at the MP-CP cleavage site. Two bands were probably detected because of an internal initiation arising at the second methionine present on the MPCAT chimeric construct. The 26 kDa protein reacted only with CAT antibodies (Fig. 2c, lanes 3 and 5) demonstrating that it corresponds to the CPCAT protein also expected after processing of the MPCAT fusion protein.
The potential proteolytic activity of the TomRSV P2 was also tested on the MP-CP cleavage site. Plasmid pMR14 (Rott et al., 1991) , encoding the entire P2, was linearized by XbaI, transcriptions were carried out with T7 RNA polymerase to give transcripts tr-TomRSV RNA-2 and unlabelled translations of these transcripts were done in NT-RRLS for 1 h. After incubation of [3~S]methionine labelled tr-MPCAT translation products with unlabelled tr-TomRSV RNA-2 translation products, only bands corresponding to the unprocessed MPCAT translation products were observed (Fig. 2b,  lane 4) .
These results show that polyprotein P1 but not polyprotein P2 possesses a proteolytic activity able to process in trans the MP-CP cleavage site present on the MPCAT fusion protein. Our results indicate that this proteolytic activity also exists on the protein encoded by pT7-PRO.
His 1283 probably belongs to the catalytic triad
From the predictions of Bazan & Fletterick (1988) and of Gorbalenya et al. (1989) and also by homology with the previously mutagenized GFLV 3C-related protease (Margis et al., 1992) , His 1~8a was predicted to be the base component of the catalytic triad of the TomRSV 3C-related protease (Fig. 1) . To verify this hypothesis and also to possibly generate an inactive protease as a control for the precursor processing studies, plasmid pT7-PRO u~283D, in which His x283 was converted to Asp, was obtained by site-directed mutagenesis. The proteolytic activity of the mutated protease encoded by pT7-PRO ~1~8~D plasmid was assayed in trans on the MP-CP cleavage site. Full-length transcripts tr-PRO m283D were synthesized and unlabelled in vitro tr-PRO ua28aD translation products, produced in NT-RRLS, were mixed with [35S]methionine labelled tr-MPCAT translation products, for 3 h. Analyses of the cell-free translation products revealed that only bands corresponding to the unprocessed MPCAT translation products were observed (Fig. 2d, lane 3) . Thus, the mutated TomRSV protease is unable to process the tr-MPCAT translation products, indicating that His 1283 is required for the proteolytic activity of the TomRSV protease, in vitro.
Proteolytic activity of the TomRSV 3C-related protease in vivo
To test whether we could detect a TomRSV proteolytic activity in vivo, i.e. in plant protoplasts, we used the strategy developed by Torruelta et al. 0989), dem- onstrating the proteolytic activity of the cauliflower mosaic virus aspartic proteinase. The inserts of plasmid pT7-PRO coding for the 32 kDa TomRSV 3C-related protease and of plasmid pT7-MPCAT coding for the 56 kDa fusion protein were placed under the control of the 35S promoter, in order to direct protein synthesis in plant protoplasts (plasmids p35S-PRO and p35S-MPCAT). The MPCAT fusion protein synthesized in vivo from p35S-MPCAT would allow us to monitor the proteolytic activity of the TomRSV protease synthesized from the p35S-PRO construct. Indeed, the unprocessed 56 kDa MPCAT fusion protein (Fig. 2a) was designed such that the long (30 kDa) N-terminal extension, corresponding to the TomRSV RNA-2 region from amino acids 1073 to 1340, would inhibit the CAT activity. If the MPCAT fusion protein were processed at the MP-CP cleavage site, the AMP and CPCAT proteins with predicted molecular masses of 30 kDa and 26 kDa, respectively, would be released (Fig. 2 a) . Because the CPCAT protein contains a very short 2 kDa N-terminal extension (corresponding to the N-terminal extremity of the TomRSV coat protein), the CPCAT protein would recover the CAT activity, at least partly.
Upon transfection of N. plumbaginifolia protoplasts with p35S-MPCAT alone, only low residual CAT activity was detected (compare with mock transfected protoplasts, Fig. 3 a) . After co-transfection of N. plumbaginifolia protoplasts with both p35S-PRO and p35S-M P C A T plasmids, a substantial increase of CAT activity was observed (Fig. 3a) , suggesting that the MPCAT protein is cleaved in vivo by the TomRSV 3C-related protease. After transfection of protoplasts with p35S-PRO rI12s3D and p35S-MPCAT, the CAT activity measured was similar to that of protoplasts transfected with p35S-MPCAT alone (Fig. 3a) , indicating that His 1~8z also appears to play an essential role in the proteolytic activity of the TomRSV 3C-related protease in vivo.
To further establish that the CAT activity detected in protoplasts transfected with p35S-MPCAT and p35S-PRO is correlated with the processing of the MPCAT protein by the TomRSV protease, immunoprecipitations were performed on protoplasts labelled with [zSS]methionine. No protein was immunoprecipitated from noninfected protoplasts with either MP antibodies or CAT antibodies (Fig. 3 b, lanes 1 and 4) . After transfection of protoplasts with p35S-MPCAT, a protein of 59 kDa was immunoprecipitated with both MP and CAT antibodies (Fig. 3 b, lanes 2 and 5) , leading to the conclusion that this protein is the MPCAT fusion protein. This is in agreement with our results obtained with NT-RRLS (see Fig. 2b ). No other proteins were immunoprecipitated with either antibody, demonstrating that internal initiation events did not occur in protoplasts. After transfection ofprotoplasts with p35S-MPCAT and p35S-PRO, a 33 kDa and 26 kDa protein were immuno-precipitated with MP antibodies and with CAT antibodies, respectively (Fig. 3 b, lanes 3 and 6) . The 33 kDa protein corresponds to AMP and the 26 kDa protein to the CPCAT protein, as already shown using NT-RRLS (Fig. 2b) .
Identification of the cleavage site between the TomRSV movement and coat proteins
To identify the nature of the MP-CP cleavage site, we determined the amino acid sequence of the N-terminal region of the TomRSV coat protein by automated Edman degradation, using virus particles isolated from cucumber plants. This amino acid sequence was found to be GGSWQEG, which is identical to the amino acid sequence of the polyprotein P2 located between residues 1321 to 1327 (numbered according to P2) (Rott et al., 1991) . Thus, the MP-CP cleavage site is Q132°/G132~. This is in agreement with the estimated location of the MP-CP cleavage site deduced from our in vitro experiments (Fig. 2a) .
To confirm that the Q132°/Ga321 dipeptide is the MP-CP cleavage site recognized in vitro by the TomRSV protease, site-directed mutagenesis were performed on plasmid pT7-MPCP, which contains the MP-CP cleavage site (see Methods and Fig. 2a) . After deletion of dipeptide QI32°/G1321, plasmid pT7MPCPAQG was obtained. As a control, dipeptide E132e/G 1327, another potential cleavage site, was also deleted to give plasmid pT7MPCPAEG. As expected, maturation experiments revealed that in vitro processing was completely abolished by deletion of Q13~°/G~321, while it remained unaffected by deletion of E1326/G 1327 (results not shown).
Substitution of His ~45~ by Leu leads to an inactive TomRS V protease
The TomRSV MP-CP cleavage site, Q/G, is similar to the como-, poty-and picornavirus polyprotein cleavage sites but differs from the cleavage sites of the subgroup I nepovirus polyproteins identified so far. According to Bazan & Fletterick (1988 and Gorbalenya et al. (1989) , His ~45x located in the putative substrate binding pocket of the TomRSV protease (Fig. 1) is predicted to be involved in the cleavage site specificity.
To test whether His 14ax is required for the proteolytic activity of the TomRSV 3C-related protease at the RomRSV MP-CP cleavage site, plasmid pT7-PRO H~451r' , in which His 1451 is replaced with Leu, was obtained by site-directed mutagenesis. This would partially reconstitute the substrate binding pocket of subgroup I nepovirus proteases. Transcripts tr-PRO r~1451r were synthesized from EcoRI-linearized pT7-PRO ru45~L.
Maturation experiments were conducted by mixing [35S]methionine labelled tr-MPCAT translation products with unlabelled tr-PRO n14~1L translation products. The pattern of MPCAT translation products obtained revealed that tr-PRO Hla51L translation products were unable to cleave tr-MPCAT translation products (Fig.  2d, lane 4) . The construct encoding the PRO ala~lL TomRSV protease was also placed under the control of the 35S promoter (see Methods), to give plasmid p35S-PRO r~1451L. After co-transfection of plant protoplasts with p35S-MPCAT and p35S-PRO H14~lL, the CAT activity measured was similar to that of protopolasts transfected with p35S-MPCAT alone (Fig. 3a) . We concluded that this mutated protease was inactive both in vitro and in vivo. Thus, our results provide evidence that His 145x plays an essential role in the proteolytic activity of the TomRSV 3C-related protease.
Discussion
In this paper, we have cloned the region of TomRSV RNA-1, corresponding to the putative 3C-related protease. We have studied the proteolytic activity of the TomRSV 3C-related protease in trans, on the TomRSV MP-CP cleavage site, using an in vitro cell-free expression system, and an in vivo transient expression system. The fusion of the TomRSV MP-CP cleavage site to the CAT protein allowed us to follow the processing both in vitro and in vivo by immunoprecipitation with CAT antibodies and by direct measure of the CAT activity. Because of its simplicity, the in vivo plant protoplast system coupled with the measure of the CAT activity will be used to further characterize the processing of the TomRSV polyproteins and the regulation of expression of viral genes products.
We showed that both the entire polyprotein P 1 and the protein encoded by the pT7-PRO plasmid (which corresponds to the putative TomRSV 3C-related protease, the entire putative VPg, and a small region of the polymerase), are able to process in trans the TomRSV MP-CP cleavage site. Further studies are underway that will aim at comparing the proteolytic activities of the entire TomRSV P1, of the mature TomRSV 3C-related protease and of different precursors of the protease. Indeed, differential proteolytic activities of precursor and mature forms of the GFLV and CPMV 3C-related proteases have been shown on different GFLV and CPMV cleavage sites, respectively (Margis et al., 1994; Dessens& Lomonossoff, 1992) . In addition, the proteolytic activity of the CPMV 3C-related protease is also regulated by a co-factor of this protease, encoded by the CPMV B-RNA (Peters et al., 1992) .
Although we demonstrated proteolytic activity of the TomRSV protease encoded by the pT7-PRO in trans on a P2 cleavage site, attempts to demonstrate an autocatalytic processing of this protease were unsuccessful. Time course experiments on production of [3~S]methionine labelled tr-PRO translation products in NT-RRLS did not result in processing of the 32 kDa TomRSV protease precursor (data not shown). However, based on the predictions of Rott et al. (1995) , the 32 kDa protein encoded by the pT7-PRO construct should contain the cleavage site between the VPg and protease and that between the protease and polymerase. One possibility is that processing at these cleavage sites is relatively inefficient as demonstrated for the GFLV cleavage site between the VPg and protease (Margis et al., 1994) and for the TBRV cleavage site between the protease and polymerase (Demangeat et al., 1990) . It is also possible that the cleavage sites recognized by the TomRSV protease are different from those predicted by Rott et al. (1995) . For instance, the dipeptide Ql~95/E1496 could be an alternative candidate to the predicted dipeptide Q146S/M1466 for the cleavage site between the protease and the polymerase. If this site is recognized by the products of the pT7-PRO construct, autocatalytic processing would probably not be detected, because the Q/E dipeptide is only separated by 13 amino acids from the C-terminal extremity of the protein.
The mutated TomRSV protease encoded by pT7-PRO H12s3D, in which the putative His of the catalytic triad ( Fig. 1) is replaced by Asp, lost its proteolytic activity. Inactive poliovirus 3C-protease, and CPMV and TEV 3C-related proteases were also obtained after mutation of the His potentially belonging to the catalytic triad (H~immerle et al., 1991; Dessens& Lomonossoff, 1991; Dougherty et al., 1989a) . Margis & Pinck (1992) also predicted the His of the GFLV 3C-related protease as the base component of the GFLV protease catalytic triad (see Fig. 1 ). Thus, our results are fully consistent with the suggestion that His ~283 constitutes the base component of the putative catalytic triad of the TomRSV 3C-related protease. The amino acid sequence of the TomRSV 3C-related protease shows a greater degree of overall similarity to that of the GFLV 3C-related protease than to those of the picorna-, como-, poty-and other subgroup I nepovirus proteases (Rott et al., 1995) . However, the TomRSV 3C-related protease possesses a His at position 1451, in its putative substrate binding pocket (as found in the substrate binding pocket of the picorna-, como-and potyvirus proteases), instead of the typical Leu found at this position in the substrate binding pocket of the subgroup I nepovirus 3C-related proteases (Fig. 1) . Our results show that an inactive protease is obtained after substitution of His 145~ by Leu. According to the model of Bazan & Fletterick (1988) and Gorbalenya et al. (1989) , we propose that His ~45~ is involved in the recognition of the TomRSV MP-CP cleavage site. Substitutions of the corresponding His of the poliovirus 3C protease (His TM, numbered according to the poliovirus 3C protease) by Gly or Arg also resulted in inactive proteases (Ivanoff et al., 1986; Andino et al., 1993) . Interestingly, a mutated GFLV protease, in which the typical Leu belonging to the substrate binding pocket has been replaced by a His also lost its proteolytic activity (Margis & Pinck, 1992) .
Recent studies of X-ray crystal structures of the hepatitis A virus and of human rhinovirus 3C proteases have revealed that, in addition to the typical His of the substrate binding pocket, other amino acids, predominantly hydrophobic, are part of the substrate binding pocket (Allaire et al., 1994; Matthews et al., 1994) . Similar hydrophobic residues flank His 145~ of the Tom-RSV 3C-related protease and are also conserved in the proteases of the other nepoviruses of subgroup I, as well as in the CPMV protease (Fig. 1) . They may therefore be part of the substrate binding pocket of these various proteases.
The determination of the first TomRSV polyprotein cleavage site, Q/G, led to the suggestion that TomRSV polyprotein cleavage sites more closely resemble the picorna-, como-and potyvirus polyprotein cleavage sites than the cleavage sites of polyproteins from subgroup I nepoviruses. Moreover, conserved amino acids present around the cleavage sites have been demonstrated to regulate the processing activity (Dougherty et al., 1989 b; Bazan & Fletterick, 1990) . It is noteworthy that a serine exists at the -4 position in the MP-CP cleavage site (see Rott et al., 1991 , for the sequence of TomRSV RNA-2). Serines at the -4 or at the -5 position are also present in all the GFLV cleavage sites (Ritzenthaler et al., 1991) . Identification of other TomRSV cleavage sites is now required, to confirm the presence of this Ser at this specific position and also to study its potential role in the regulation of cleavage efficiency.
Our results suggest that TomRSV 3C-related protease and TomRSV MPCP cleavage site share characteristics of the 3C-related proteases and cleavage sites of subgroup I nepoviruses, and of poty-and comoviruses. Because TomRSV is the only sequenced member of subgroup II nepoviruses, it would be interesting to determine whether other proteases of subgroup II nepoviruses also have characteristics similar to the TomRSV 3C-related protease.
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